Document Detail

Hyperglycemia independently increases the risk of perioperative stroke, myocardial infarction, and death after carotid endarterectomy.
MedLine Citation:
PMID:  16723885     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: Clinical and experimental evidence suggests that hyperglycemia lowers the neuronal ischemic threshold, potentiates stroke volume in focal ischemia, and is associated with morbidity and mortality in the surgical critical care setting. It remains unknown whether hyperglycemia during carotid endarterectomy (CEA) predisposes patients to perioperative stroke and operative related morbidity and mortality. METHODS: The clinical and radiological records of all patients undergoing CEA and operative day glucose measurement from 1994 to 2004 at an academic institution were reviewed and 30-day outcomes were assessed. The independent association of operative day glucose before CEA and perioperative morbidity and mortality were assessed via multivariate logistic regression analysis. RESULTS: One thousand two hundred and one patients with a mean age of 72 +/- 10 years (748 men, 453 women) underwent CEA (676 asymptomatic, 525 symptomatic). Overall, stroke occurred in 46 (3.8%) patients, transient ischemic attack occurred in 19 (1.6%), myocardial infarction occurred in 19 (1.6%), and death occurred in 17 (1.4%). Increasing operative day glucose was independently associated with perioperative stroke or transient ischemic attack (Odds ratio [OR], 1.005; 95% confidence interval [CI], 1.00-1.01; P = 0.03), myocardial infarction (OR, 1.01; 95% CI, 1.004-1.016; P = 0.017), and death (OR, 1.007; 95% CI, 1.00-1.015; P = 0.04). Patients with operative day glucose greater than 200 mg/dl were 2.8-fold, 4.3-fold, and 3.3-fold more likely to experience perioperative stroke or transient ischemic attack (OR, 2.78; 95% CI, 1.37-5.67; P = 0.005), myocardial infarction (OR, 4.29; 95% CI, 1.28-14.4; P = 0.018), or death (OR, 3.29; 95% CI, 1.07-10.1; P = 0.037), respectively. Median and interquartile range length of hospitalization was greater for patients with operative day glucose greater than 200 mg/dl (4 d [interquartile range, 2-15 d] versus 3 d [interquartile range, 2-7 d]; P < 0.05). CONCLUSION: Independent of previous cardiac disease, diabetes, or other comorbidities, hyperglycemia at the time of CEA was associated with an increased risk of perioperative stroke or transient ischemic attack, myocardial infarction, and death. Strict glucose control should be attempted before surgery to minimize the risk of morbidity and mortality after CEA.
Matthew J McGirt; Graeme F Woodworth; Benjamin S Brooke; Alexander L Coon; Shamik Jain; Donald Buck; Judy Huang; Richard E Clatterbuck; Rafael J Tamargo; Bruce A Perler
Related Documents :
20553635 - Vital exhaustion and cardiovascular prognosis in myocardial infarction and heart failur...
1633075 - Effects of nitrates on mortality in acute myocardial infarction and in heart failure.
15820165 - Effect of both elevated troponin-i and peripheral white blood cell count on prognosis i...
12649515 - Comparison of triflusal and aspirin for prevention of vascular events in patients after...
18609065 - The anti-inflammatory effect of bradykinin preconditioning in coronary artery bypass gr...
12928745 - Amyloid of heart and lungs in a patient with low output syndrome after coronary artery ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Neurosurgery     Volume:  58     ISSN:  1524-4040     ISO Abbreviation:  Neurosurgery     Publication Date:  2006 Jun 
Date Detail:
Created Date:  2006-05-25     Completed Date:  2006-07-20     Revised Date:  2008-06-24    
Medline Journal Info:
Nlm Unique ID:  7802914     Medline TA:  Neurosurgery     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1066-73; discussion 1066-73     Citation Subset:  IM    
Department of Neurosurgery, The Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Carotid Stenosis / complications*,  surgery*
Endarterectomy, Carotid / adverse effects*,  mortality*
Hyperglycemia / complications*
Ischemic Attack, Transient / epidemiology
Middle Aged
Myocardial Infarction / epidemiology,  etiology*
Risk Factors
Stroke / epidemiology,  etiology*
Treatment Outcome
Comment In:
Perspect Vasc Surg Endovasc Ther. 2007 Dec;19(4):415   [PMID:  18287157 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid he...
Next Document:  Single nucleotide polymorphisms of tissue inhibitor of metalloproteinase genes in familial moyamoya ...